Neodrol 500 Mg Inj

Other Details:
- Active Ingredient: Methylprednisolone Sodium Succinate USP (500 mg strength)
- Dosage Form: Sterile Lyophilized Powder for Injection (Dry Vial)
- Packaging Unit: Single 500mg Vial with Diluent per Box
- Therapeutic Class: High-Dose Corticosteroids / Glucocorticoids
- Prescription Status: Rx – Prescription Drug Required
- Shelf Life: 24 Months from manufacturing date
- Target Channels: Critical Care Units, Emergency Medical Distributors, Institutional Hospital Suppliers
- Minimum Order Quantity: 20 Vials
- Supply Status: Continuous ex-stock availability for immediate pan-India transit

Product Name: Neo-Drol 500mg Injection (Methylprednisolone Sodium Succinate for Injection USP)
Brand Name: Neon Laboratories Ltd (Distributed by Shivshrushti Surgimed)
Description: Neo-Drol 500mg Injection is a high-potency, fast-acting synthetic glucocorticoid corticosteroid containing Methylprednisolone Sodium Succinate USP. This high-dose critical care formulation is heavily utilized in emergency settings and intensive care units (ICUs) for rapid anti-inflammatory and intensive immunosuppressive therapy. It is primarily indicated for treating acute spinal cord injuries, severe anaphylactic shock, acute exacerbations of multiple sclerosis, status asthmaticus, and systemic lupus erythematosus (SLE) flare-ups. It is also used as a pulse therapy intervention to prevent acute graft rejection following organ transplant procedures.
Safety Requirements: This is a highly potent corticosteroid formulation intended strictly for slow Intravenous (IV) infusion or Intramuscular (IM) administration under direct clinical supervision—never self-administer. Close biometric monitoring of blood pressure, blood glucose levels, and serum electrolytes is critical, particularly in patients with diabetes, cardiac complications, or hypertension. It should not be administered to individuals suffering from systemic fungal infections or active viral diseases. Do not administer live or live-attenuated vaccines concurrently during high-dose therapy. Dispose of all used dry powder vials and mixing solutions following clinical bio-hazard standards.
Storage Requirement: Store the dry powder vial securely at a controlled room temperature between 20 and 25 degrees Celsius. Protect the inventory from high humidity, extreme structural damage, and direct ambient or thermal light exposure. Once reconstituted with sterile water, the injection solution must be utilized immediately or stored strictly according to the manufacturer’s clinical guidelines. Keep all packaging well isolated from children and unauthorized handlers.